Egg Allergy Drug Pipeline Research 2024 Featuring Aimmune Therapeutics, DBV Technologies, and ASIT Biotech
April 12, 2024 09:59 ET
|
Research and Markets
Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "Egg allergy - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
Peanut Allergy Drug Landscape Analysis Report 2024: Comprehensive Insights of 12+ Companies and 15+ Pipeline Drugs
April 11, 2024 09:11 ET
|
Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Peanut Allergy - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Peanut Allergy - Pipeline Insight,...
Allergy Immunotherapy Soars: Anticipating a $2.69 Billion Market by 2028 with an Impressive CAGR of 8.12%
February 05, 2024 04:41 ET
|
Research and Markets
Dublin, Feb. 05, 2024 (GLOBE NEWSWIRE) -- The "Global Allergy Immunotherapy Market (2023-2028) by Type, Application and Distribution Channel, and Geography, Competitive Analysis, Impact of Covid-19,...